QIAGEN Ltd.

Industry / private company


Location: Manchester, United Kingdom (GB) GB

ISNI: 0000000404513823

ROR: https://ror.org/04hyg4h58

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Identifying fibroblast growth factor receptor genetic alterations using RNA-based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatment (2020) Wang S, Burgess M, Major C, English A, Sweeney M, Hartmann A Journal article Clinical Performance of QIAGEN Fibroblast Growth Factor Receptor (FGFR) Assay for the Detection of FGFR Alterations in Erdafitinib-Treated Patients with Metastatic or Locally Advanced, Surgically Unresectable, Urothelial Cancer (2019) Major C, Wang S, Burgess M, English A, Sweeney M, Hartmann A Conference contribution